Gotteland M, Desauty G, Delarue J C, Liu L, May E
CNRS, IRSC, Laboratory of Molecular Oncology, Villejuif, France.
Mol Cell Endocrinol. 1995 Jul;112(1):1-13. doi: 10.1016/0303-7207(95)03576-s.
By using the PCR-SSCP technique we characterized various ER-specific RNA species present in a series of primary breast cancers, as well as in cell lines established from breast carcinomas and in mammary gland tissues from healthy specimens. A series of six truncated messenger RNAs generated by alternative splicing was characterized. These RNAs correspond to specific deletions of one (exons 2-7, except exon 6) or two (exons 3 + 4) exons. All these RNA variants are observed in each one of the analyzed RNAs, regardless of origin. In addition, the relative amount of these different variants in ER + tumors is comparable to that measured in ER - tumors and healthy mammary gland tissues. This data suggests that tumor progression is not related to the emergence of any of the ER mRNA variants.
通过使用聚合酶链反应-单链构象多态性(PCR-SSCP)技术,我们对一系列原发性乳腺癌、从乳腺癌建立的细胞系以及健康标本的乳腺组织中存在的各种雌激素受体(ER)特异性RNA种类进行了表征。鉴定出了一系列由可变剪接产生的六个截短的信使RNA。这些RNA对应于一个外显子(外显子2-7,外显子6除外)或两个外显子(外显子3 + 4)的特定缺失。所有这些RNA变体在每个分析的RNA中均有观察到,无论其来源如何。此外,这些不同变体在ER阳性肿瘤中的相对量与在ER阴性肿瘤和健康乳腺组织中测得的量相当。该数据表明肿瘤进展与任何ER mRNA变体的出现无关。